Pacira | PCRX - Market Capitalization


Pacira reported $1.14B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Astellas Pharma JPY 4.13T 430.55B Apr/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Coherus Biosciences USD 172M 19M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025